About this trial
Application of High-Frequency Spinal Cord Stimulation (HF-SCS) in the Treatment of Painful Diabetic Peripheral Neuropathy (PDPN): A multicenter, randomized controlled study comparing its clinical efficacy with traditional spinal cord stimulation for PDPN. The study aims to observe the impact of HF-SCS on the neurological function and microcirculation of PDPN patients, elucidating the correlation between the underlying diabetes and the efficacy of HF-SCS therapy on PDPN. The goal is to enhance the treatment standards for PDPN, improve the quality of life for this population, and overall treatment outcomes. Simultaneously, the study aims to contribute evidence-based medicine for the mechanistic exploration of PDPN.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with diabetes, aged between 18 and 80 years old;
Symmetrical pain in the distal lower extremities with or without dysesthesia;
Duration of symptoms exceeding 6 months;
Pain described as stabbing and/or electric shock-like and/or burning sensation;
Disqualifiers
Concurrent severe cardiovascular and cerebrovascular diseases;
History of lumbar spine surgery, trauma, or spinal canal stenosis within the past 6 months, or a history of lumbar spine surgery, trauma, or spinal canal stenosis that would impact the SCS surgery and pain assessment in this study;
Presence of radicular symptoms;
Other spinal abnormalities, such as benign or malignant tumors, congenital abnormalities of the spine, spinal instability, etc.;
Trial design
Parallel
Treatments tested in this trial
spinal cord stimulator
DeviceA spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain.
high frequency spinal cord stimulation
DeviceA spinal cord stimulator is an implanted device that sends low levels and high frequency of electricity directly into the spinal cord to relieve pain.
Treatment groups
Trial outcomes
Primary outcomes
treatment effectiveness
The treatment effectiveness is assessed based on the reduction of Numeric Rating Scale (NRS) scores for pain three months after treatment compared to before treatment. Specifically, a decrease of ≥50% in the pain NRS score \[(NRS score at 3 months post-treatment - NRS score before treatment) / NRS score before treatment\] ≥ 50% is considered the criterion for treatment effectiveness
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fan BiFa
Lead sponsor
China-Japan Friendship Hospital
Sponsor institution
Peking University Third Hospital
Collaborator
Xuanwu Hospital, Beijing
Collaborator
Civil Aviation General Hospital
Collaborator
Shenzhen Sixth People's Hospital
Collaborator
Beijing Tiantan Hospital
Collaborator